Economic Impact of Respiratory Syncytial Virus Prefusion F Protein-Based Vaccination and Nirsevimab Prophylaxis on Respiratory-Syncytial-Virus-Associated Disease Among Japanese Infants

Only seasonal RSVpreF strategy is cost-effective under the JPY5 000 000/US$33 333 per QALY willingness-to-pay threshold.

Authors

Institutions

Publication Details

Journal
Value in Health
Published
2026-02-01
DOI
https://doi.org/10.1016/j.jval.2026.01.010
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Economic Impact of Respiratory Syncytial Virus Prefusion F Protein-Based Vaccination and Nirsevimab Prophylaxis on Respiratory-Syncytial-Virus-Associated Disease Among Japanese Infants

Masahide Kondo, Shu-Ling Hoshi, Xerxes Seposo
Value in Health
Respiratory viral infections research
article

Economic Impact of Respiratory Syncytial Virus Prefusion F Protein-Based Vaccination and Nirsevimab Prophylaxis on Respiratory-Syncytial-Virus-Associated Disease Among Japanese Infants

Masahide Kondo, Shu-Ling Hoshi, Xerxes Seposo
article en

Abstract

Only seasonal RSVpreF strategy is cost-effective under the JPY5 000 000/US$33 333 per QALY willingness-to-pay threshold.

Value in Health
University of Tsukuba (JP), Hokkaido University (JP), Tsukuba University of Technology (JP)
Zero hunger
Openalex Percentile: Top 68%
Respiratory viral infections research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.